Searching for a quality and dependable source of fine tobaccos and cigars on the internet? Click here to browse our complete listing of quality and vintage cigars and cigar accessories, and see for yourself how a quality tobacco supply can make a difference! Look here

BACKGROUND ON THE HEALTHY START SMOKING CESSATION PROGRAMAs a community based organization whose goal is to promote comprehensive prenatal and infant health services, the Healthy Start Coalition of Pinellas is dedicated to working to improve the health outcomes of mother and child. In line with these ideals, Healthy Start has instituted an outreach program similar lascabrillascigar to the one described in the Windsor study in which clients are provided the manual "A Pregnant Woman''s Self-Help Guide to Quit Smoking." Additionally, qualified personnel are hired to provide brief counseling sessions with the clients and to encourage the maintenance of a nonsmoking status. This paper presents an analysis of the intervention put forth by the Healthy Start Coalition of Pinellas. The purpose of the Healthy Start smoking cessation program is to discourage maternal smoking during pregnancy, with the anticipation of promoting a positive birth experience. Results reported in this writing are based on outcome measures of women lascabrillascigar enrolled in the program from December 1997 to December 1999.

In the present prospective, randomized, double-blind study with 144 smokers, 23.7% of the patients receiving placebo stopped lascabrillascigar smoking, compared to 55.9% of the patients receiving nortriptyline (p < 0.001). Individuals were considered to have stopped smoking if they claimed total abstinence from cigarette smoking for at least 1 week. Our results were comparable to those of another randomized study by Hurt et al, (16) which included 615 patients who had been treated with bupropion. In the sixth week lascabrillascigar of the lascabrillascigar study, the abstinence rate was 19% for the group receiving placebo and 44.2% for the group receiving bupropion (p < 0.001).Prochazka et al (18) in a randomized, double blind, placebo-controlled study with 214 patients, evaluated the effects of nortriptyline on the rate of lascabrillascigar ceasing to smoke. The success rate for the group that received the active drug was 50%, compared to 32% for the group receiving placebo. Only 12% of the patients had a history of depression, compared to 48% in the population of our study. Despite the difference between the two studies in the methodologies used to obtain this information (in our study, the report on psychiatric treatment for the diagnosis of depression was considered as previous history of depression, while in the study by Prochazka et al, (18) a structured questionnaire was applied [ie, the diagnostic interview schedule]), the difference between the two populations could explain the different in the rate of success in ceasing to smoke.